1-2 of 2
Hans J. Salwender
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measurable Residual Disease Monitoring in AML With FLT3-ITD Treated With Intensive Chemotherapy Plus Midostaurin

Frank G. Rücker, Lars Bullinger, Sibylle Cocciardi, Sabrina Skambraks, Tamara J Luck, Daniela Weber, Julia Krzykalla, Ema Pozek, Isabelle Janina Schneider, Andrea Corbacioglu, Verena I. Gaidzik, Annika Meid, Dr., Sophia Aicher, Frank Stegelmann, Anika Schrade, Frauke Theis, Walter Fiedler, Helmut R. Salih, Gerald G. Wulf, Hans J Salwender, Thomas Schroeder, Katharina S Götze, Michael W.M. Kühn, Michael Lübbert, Richard F. Schlenk, Axel Benner, Felicitas R. Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner
Journal: Blood Advances
Blood Adv bloodadvances.2024013758.
https://doi.org/10.1182/bloodadvances.2024013758
Published: 2024
Includes: Supplemental data
Journal Articles

Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM

Clinical Trials & Observations
Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias K. Mai, Marc S. Raab, Hans J. Salwender, Roland Fenk, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M. Asemissen, Bernhard Heilmeier, Uta Bertsch, Stefanie Huhn, Carsten Müller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Journal: Blood Advances
Blood Adv (2023) 7 (3): 379–383.
https://doi.org/10.1182/bloodadvances.2022008005
Published: 2023
Includes: Supplemental data